arXiv:2606. 02507v1 Announce Type: cross Abstract: Inverse materials design is shifting materials discovery from forward prediction to targeted proposal of candidates that satisfy objectives under physical constraints.
By Anand Babu, Rog\'erio Almeida Gouv\^ea, Gian-Marco Rignanese
arXiv:2607. 23404v1 Announce Type: new Abstract: Self-driving laboratories increasingly rely on multi-fidelity Bayesian optimization (MFBO) to balance cheap, approximate evaluations against scarce, expensive ones, with a predictive surrogate at its core.
By Jaewook Lee, Ethan Errington, Christian D. Lorenz, Miao Guo
arXiv:2606. 30170v1 Announce Type: cross Abstract: Generative molecular design is shaped by simple proxy benchmarks for drug-like properties and models pretrained on large pharmaceutical datasets.
By Matthias Blaschke, Daniel Kienzle, Zsuzsanna Koczor-Benda, Julian Lorenz, Rainer Lienhart, Fabian Pauly
The paper presents a portfolio-based approach to constrained multi-objective Bayesian optimization for materials design, framing acquisition‑function selection as an adaptive policy problem. Two controllers—UCB‑Bandit, a modified UCB multi‑armed bandit, and Agentic‑Switch, a multi‑agent system powered by a large language model—were tested against fixed‑policy baselines on synthetic benchmarks and two real materials design case studies. The adaptive policies achieved competitive results in cumulative feasibility counts and feasible hypervolume improvement, outperforming individual acquisition functions that excelled only in a single metric.
By Sushant Sinha, Christofer Hardcastle, Robert Robinson, Shakti Prasad Padhy, Brent Vela, Douglas Allaire, Raymundo Arroyave
arXiv:2601. 21527v3 Announce Type: replace-cross Abstract: Artificial intelligence (AI) has transformed materials discovery, enabling rapid exploration of chemical space through generative models and surrogate screening.
By Sajid Mannan, Rupert J. Myers, Rohit Batra, Rocio Mercado, Lothar Wondraczek, N. M. Anoop Krishnan
arXiv:2607. 12488v1 Announce Type: new Abstract: Molecular optimization in drug discovery, materials design, and catalysis requires searching vast chemical spaces under tight evaluation budgets, since high-fidelity oracles and experimental measurements are costly.
By Sarina Kopf, Cristina Nevado, Philippe Schwaller